Results 241 to 250 of about 585,172 (342)

Caring Minds [PDF]

open access: yes, 2017
UTHealth Cizik School of Nursing
core   +1 more source

The Structure of Informal Learning in the Workplace—An Experience Sampling Approach

open access: yesHuman Resource Development Quarterly, EarlyView.
ABSTRACT This paper complements retrospective approaches to researching informal learning in the workplace with experience sampling. Since (conscious) informal learning is becoming increasingly important for successfully keeping pace with rapid changes in working environments, a clear understanding of the construct and its precise measurement are ...
Katja Häußermann, Tina Seufert
wiley   +1 more source

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi   +3 more
wiley   +1 more source

The Disquiet of Quiet Quitting: Definitional Clarity, Theoretical Pathways, and Future Research

open access: yesHuman Resource Management, EarlyView.
ABSTRACT Quiet quitting (QQ) has emerged as a prominent topic in both popular press and academic research, reflecting shifts in employees' engagement, effort allocation, and responses to contemporary work pressures. This review synthesizes findings from 11 papers published in a recent Special Issue on The Disquiet of Quiet Quitting.
Solon Magrizos   +5 more
wiley   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy